RTF/RTU Vials Market Research Report: By Packaging Type (Nest and Tub, Tray), Color (Clear, Amber), Placing Method (Side-Up Inside, Down-Upside), Filling Product (Liquid, Lyophilized) - Global Industry Analysis and Demand Forecast to 2030

Market Overview

The global RTF/RTU vials market generated $306.5 million revenue in 2020, and it is expected to grow at a CAGR of 14.5% during the forecast period (2021–2030). Factors responsible for the growth of the market include need of pharmaceutical companies to increase their operational efficiency and growing usage of injectable drugs. Moreover, rising production capacity of vial manufacturers, surging healthcare expenditure, and growing pharmaceutical industry are also propelling the market growth.

The COVID-19 pandemic has given impetus to the pharmaceutical industry and the overall RTF/RTU vials market, worldwide. Several RTF/RTU vial companies are increasing their production capacity in order to meet the growing product demand from the pharmaceutical industry, research organizations, and biotech companies. An unprecedented push to manufacture billions of doses this year alone has led the market growth at an exceptional rate.

Clear vials to retain its market position during the forecast period

Based on color, the RTF/RTU vials market is categorized into clear and amber vials. The market for clear vials accounted for the larger revenue share in 2020, and it is expected to showcase a higher growth rate during the forecast period. This is due to the fact that amber vials are only used for those injectables that require protection from sunlight, and since there are fewer injectables that need such protection, clear vials are more commonly used.

Side-up inside placing method dominates the market

Based on placing method, the RTF/RTU vials market is bifurcated into side-up inside and down-upside. Of the two, the side-up inside placing method obtained the larger market share in 2020, and it is expected to showcase a higher growth rate during the forecast period. The side-up inside method is used in the nest-and-tub packaging method, and since the demand for this packaging method is higher than for the tray method, the side-up inside placing method finds a wider application.

Europe to hold major market share in coming years

Globally, Europe held the largest share in the RTF/RTU vials market in 2020, and it is expected to lead the market during forecast period as well. This is attributed to the presence of a large number of RTF/RTU vial manufacturers in the region, such as Schott AG, Gerresheimer AG, Stevanato Group, and SGD S.A. Further, the increasing awareness on the newly developed drugs and high per capita income in the region, along with a large aging population, are driving the demand for RTF/RTU vials.

Need of pharmaceutical companies to increase their operational efficiency

Drug manufacturers are focusing on streamlining their operations and concentrating on their core competencies, such as production and processing. As a result, they are using RTF/RTU vials, which remove several steps, such as cleaning, dehydrogenating, and sterilizing the vials. These steps are not key practices for a pharmaceutical company, and they decrease their overall operational efficiency. Therefore, nowadays, pharmaceutical companies are preferring fill/finish technologies/packaging that can guarantee sterility without substantial expenditure. The majority of the processing problems are eliminated by RTF/RTU systems because packing is pre-prepared and the only step left in the process is filling and finishing the package. This factor drives the growth of the RTF/RTU vials industry.

Growing usage of injectable drugs

The injectable drug delivery industry is predicted to progress significantly in coming years, as a result of the rising diabetes and cancer incidence. Drugs are injected into the body for autoimmune diseases, oncological disorders, hormonal disorders, orphan diseases, and various other purposes. Injectables are beneficial for patients who are asleep or comatose, or unable to consume medicines orally, nasally, or via other means that require motor functions. Therefore, the rising demand for injectable drugs is propelling the requirement for vials, including RTF/RTU vials, as these variants are mainly use for injectable drugs. Hence, growing use of injectable drugs is boosting the demand for RTF/RTU vials, globally.

Market players involve in product launches and increasing their production to gain significant position

Some of the major players operating in the global RTF/RTU vials market include SCHOTT AG, Gerresheimer AG, SGD S.A., Stevanato Group, Nipro Corporation, China Lemon Trading Co. Ltd., Ningbo Zhengli Pharmaceutical Packaging Co. Ltd., and DWK Life Sciences GmbH. In recent years, the players in the industry have been involved in product launches to improve their position.

In October 2020, SGD S.A. launched EasyLyo vials of 20 ml and 25 ml capacity; new 50 ml flint vials; and 50 ml amber and 100 ml International Organization for Standardization (ISO) injectable vials, which are manufactured from Type I molded glass.

In March 2019, Gerresheimer AG introduced two new Type I vials, namely Gx Elite and Gx RTF, made of borosilicate glass. The vials are shatter-resistant, highly durable, and free of cosmetic defects.

Explore more about this report - Request free sample

Some of Key Players in RTF/RTU Vials Market Include:

Market Size Breakdown by Segment

The global RTF/RTU vials market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.

Based on Packaging Type

• Nest and Tub
• Tray

Based on Color

• Clear
• Amber

Based on Placing Method

• Side-Up Inside
• Down-Upside

Based on Filling Product

• Liquid
• Lyophilized

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Netherlands
• APAC
  • China
  • Japan
  • India
  • Australia
• LATAM
  • Brazil
  • Mexico
  • Argentina
• MEA
  • Saudi Arabia
  • South Africa
  • U.A.E.